News & Views
Big Pharma Given Access To Your Private Medical Records
Date: 09/12/11
Keywords: NHS, National Health Service, Alternative medicine, modern medicine, Natural remedies, Vitamin C
Earlier this week, the UK Prime Minister David Cameron announced plans that will allow seriously ill patients to have access to 'promising' new drugs, as much as a year before they are licenced for general use.
In other words, drugs that are still in development will be tested in hospital trials on terminally ill patients.
This so-called double-dip recession is bringing the worst
out in politicians... especially when they start to see
pharmaceuticals as a cornerstone of economic growth.
How crazy is that?
Earlier this week, the UK Prime Minister David Cameron announced plans that will allow seriously ill patients to have access to 'promising' new drugs, as much as a year before they are licenced for general use.
In other words, drugs that are still in development will be tested in hospital trials on terminally ill patients.
Desperate measures
On the surface, Cameron's reforms may sound like a good idea... giving patients access to medicine they desperately need... boosting the £50bn 'life sciences industry' (Big Pharma!) with a £180 million investment to develop new concoctions with the aim of attracting global investments, which might eventually boost the economy.
However, this master plan has anything but patients' best interests at heart. For starters, as far as I'm concerned, as long as a drug is still in development, it's nothing more than an untested, ineffective and dangerous chemical concoction!
Secondly, Cameron's reforms involve Big Pharma being given access to patient records and other National Health Service (NHS) data. This will enable drug companies to target patients who most need their 'yet to be approved drugs'... basically, allowing them to run clinical trials in hospitals and turning sick patients into guinea pigs!
Lastly, Cameron argues that his plan will benefit both the patient and Big Pharma... However, I fail to see how a dying cancer patient will benefit from taking part in a drug trial of a concoction that's not been properly tested for its safety and effectiveness? Without sounding unsympathetic to anyone suffering from a life-threatening disease, this form of 'economic growth' sounds more like a death sentence.
Time to change
Speaking about these 'reforms' Cameron said: "We have got to change radically — the way we innovate, the way we collaborate...".
If that's really where he's going with this, then why not invest £180m in the UK's £14bn supplement industry, instead of clamping down on it?
A case in point: If you visit the Cancer Research UK (Britain's biggest mainstream cancer research charity) website and you search the phrase "ascorbic acid", you will find a 2008 article about a laboratory study that indicated vitamin C might reduce the effectiveness of cancer drugs.
No mention is made of a review of 19 clinical trials that showed how the use of antioxidant supplements (including vitamin C, of course) actually appeared to BOOST chemo effectiveness, increasing survival time and tumour responses.
Given the choice between a single lab trial and 19 trials with human subjects, Cancer Research UK went with the lab trial, which would discourage cancer patients from using antioxidant supplements... Now if that isn't a clear case of bias, I wonder what is?
See, this is what needs to change! We don't need Big Pharma to get any bigger. Neither do we need further research into more dangerous pharmaceuticals when Nature provides us with much safer and effective solutions... intravenous vitamin C being just one of many examples.
It's time for governments and the mainstream to get behind the power of Nature, stop chasing the money and start putting patients first by giving them all the options available to them. Now that will indeed be a radical change!
Sources:
Cameron accused of putting NHS on sale over plans for life sciences, publsihed online 05.12.11, guardian.co.uk
"Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren" American Journal of Clinical Nutrition, Published online ahead of print 3/10/10, ajcn.org
"Physical Interventions to Interrupt or Reduce the Spread of Respiratory Viruses: Systematic Review" British Medical Journal, Vol. 399, 9/22/09, bmj.com
Back to topHow crazy is that?
Earlier this week, the UK Prime Minister David Cameron announced plans that will allow seriously ill patients to have access to 'promising' new drugs, as much as a year before they are licenced for general use.
In other words, drugs that are still in development will be tested in hospital trials on terminally ill patients.
Desperate measures
On the surface, Cameron's reforms may sound like a good idea... giving patients access to medicine they desperately need... boosting the £50bn 'life sciences industry' (Big Pharma!) with a £180 million investment to develop new concoctions with the aim of attracting global investments, which might eventually boost the economy.
However, this master plan has anything but patients' best interests at heart. For starters, as far as I'm concerned, as long as a drug is still in development, it's nothing more than an untested, ineffective and dangerous chemical concoction!
Secondly, Cameron's reforms involve Big Pharma being given access to patient records and other National Health Service (NHS) data. This will enable drug companies to target patients who most need their 'yet to be approved drugs'... basically, allowing them to run clinical trials in hospitals and turning sick patients into guinea pigs!
Lastly, Cameron argues that his plan will benefit both the patient and Big Pharma... However, I fail to see how a dying cancer patient will benefit from taking part in a drug trial of a concoction that's not been properly tested for its safety and effectiveness? Without sounding unsympathetic to anyone suffering from a life-threatening disease, this form of 'economic growth' sounds more like a death sentence.
Time to change
Speaking about these 'reforms' Cameron said: "We have got to change radically — the way we innovate, the way we collaborate...".
If that's really where he's going with this, then why not invest £180m in the UK's £14bn supplement industry, instead of clamping down on it?
A case in point: If you visit the Cancer Research UK (Britain's biggest mainstream cancer research charity) website and you search the phrase "ascorbic acid", you will find a 2008 article about a laboratory study that indicated vitamin C might reduce the effectiveness of cancer drugs.
No mention is made of a review of 19 clinical trials that showed how the use of antioxidant supplements (including vitamin C, of course) actually appeared to BOOST chemo effectiveness, increasing survival time and tumour responses.
Given the choice between a single lab trial and 19 trials with human subjects, Cancer Research UK went with the lab trial, which would discourage cancer patients from using antioxidant supplements... Now if that isn't a clear case of bias, I wonder what is?
See, this is what needs to change! We don't need Big Pharma to get any bigger. Neither do we need further research into more dangerous pharmaceuticals when Nature provides us with much safer and effective solutions... intravenous vitamin C being just one of many examples.
It's time for governments and the mainstream to get behind the power of Nature, stop chasing the money and start putting patients first by giving them all the options available to them. Now that will indeed be a radical change!
Sources:
Cameron accused of putting NHS on sale over plans for life sciences, publsihed online 05.12.11, guardian.co.uk
"Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren" American Journal of Clinical Nutrition, Published online ahead of print 3/10/10, ajcn.org
"Physical Interventions to Interrupt or Reduce the Spread of Respiratory Viruses: Systematic Review" British Medical Journal, Vol. 399, 9/22/09, bmj.com
Click here to send to a friendShare thisPrinter friendly version
